Therogenetics: transferring GWAS technology to the clinic

Area of Science:

• Oncology
• Genetics
• Cancer Research

Background:

• Molecular subtyping of breast tumors guides clinical treatment.
• Emerging evidence suggests germline genetics may influence breast cancer metastasis.
• Factors beyond primary tumor characteristics are increasingly recognized as critical.

Purpose of the Study:

• To review evidence linking germline genetics to breast cancer metastasis.
• To highlight limitations in identifying influential germline variants.
• To propose tools for overcoming these identification challenges.

Main Methods:

• Literature review of studies on breast cancer genetics and metastasis.
• Analysis of existing evidence on germline variants and metastatic risk.
• Discussion of current technological and analytical limitations.

Main Results:

• Germline genetic factors play a role in breast cancer progression to metastasis.
• Current methods face challenges in pinpointing specific germline variants associated with metastasis.
• Identifying these variants is essential for personalized risk assessment.

Conclusions:

• Germline genetics represents a significant, yet underexplored, factor in breast cancer metastasis.
• Development of advanced tools is necessary to identify specific germline variants impacting metastatic risk.
• Future research should focus on integrating germline genetic analysis into breast cancer management.